Healthcare News

COVID-19 Vaccine: Mass Production To Begin ‘Right Now’, Ready For Supply By September

Written by David Miller

The vaccine is under the human trial phase and once the effectiveness is proved, the pharma company will produce millions of doses in a couple of months. While the company will produce the first 100 million doses for the UK as per its deal signed with the nation, it will manufacture around 2 billion doses to be supplied worldwide by mid-2021.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]